Related references
Note: Only part of the references are listed.A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients
R. Anty et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design
Naga P. Chalasani et al.
CONTEMPORARY CLINICAL TRIALS (2009)
Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases
Minoru Satoh et al.
MODERN RHEUMATOLOGY (2009)
Cytokeratin-18 fragments and biomarkers of the metabolic syndrome in nonalcoholic steatohepatitis
Yusuf Yilmaz et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Clinical Correlates of Histopathology in Pediatric Nonalcoholic Steatohepatitis
Heather M. Patton et al.
GASTROENTEROLOGY (2008)
Is Biopsy Always Necessary? Toward a Clinico-Laboratory Approach for Diagnosing Nonalcoholic Steatohepatitis in Obesity
Enzo Emanuel
HEPATOLOGY (2008)
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European liver fibrosis panel and exploring simple markers
Indra Neil Guha et al.
HEPATOLOGY (2008)
Clinicopathological significance of antinuclear antibodies in non-alcoholic steatohepatitis
Hideki Niwa et al.
HEPATOLOGY RESEARCH (2007)
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Paul Angulo et al.
HEPATOLOGY (2007)
Statins and hepatic steatosis: Perspectives from the Dallas Heart Study
Jeffrey D. Browning
HEPATOLOGY (2006)
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
V Ratziu et al.
BMC GASTROENTEROLOGY (2006)
Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?
S Yatsuji et al.
JOURNAL OF GASTROENTEROLOGY (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease
P Loria et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Insulin resistance, auto-antibodies, and nonalcoholic fatty liver disease response to letter
LA Adams et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis
SJ Coder et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2004)
Serum markers detect the presence of liver fibrosis: A cohort study
WMC Rosenberg et al.
GASTROENTEROLOGY (2004)
The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease
LA Adams et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates
P Loria et al.
DIGESTIVE DISEASES AND SCIENCES (2003)
Simultaneous activation of natural killer T cells and autoantibody production in mice injected with denatured syngeneic liver tissue
T Naito et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Share Paper
